GET DAILY SIGNALSCastellum (CTM) Delivers Mixed Q3 Results as Backlog Dips but Pipeline Surges
Key Takeaways
- Castellum reported third quarter 2026 revenue of $14.7 million, slightly below the consensus estimate of roughly $14.9 million and essentially flat compared with $14.6 million a year earlier.
- The company posted a GAAP net loss of $0.01 per share, roughly in line with analyst expectations.
- Total scheduled backlog declined to $254.5 million at September 30, 2026, down from $271.7 million at the end of the prior quarter.
- The qualified opportunity pipeline surged to approximately $1.66 billion, up sharply from $953.5 million three months earlier.
- The company maintained a debt-free balance sheet and a solid cash position heading into the fourth quarter.
- The stock declined sharply in after-hours trading following the November 5, 2026 release.
Why These Results Matter
Castellum is a defense technology services provider focused on cybersecurity, electronic warfare, and software services for U.S. government and commercial clients. Its third quarter results matter because they test whether the company can sustain the organic revenue growth and margin momentum it built through 2025, when it delivered its first-ever quarterly GAAP net income. After two quarters of rising backlog and record first-half revenue, investors were watching closely to see whether contract awards would convert into recognized revenue. The latest report showed a modest top-line miss and a slight decline in backlog, even as the company's opportunity pipeline expanded dramatically, leaving the market to weigh near-term execution against longer-term growth potential. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
Reported Results
Castellum reported revenue of $14.7 million for the third quarter ended September 30, 2026, slightly below the consensus estimate of approximately $14.9 million and essentially flat versus the $14.6 million recorded in the year-ago quarter. Gross profit came in at about $5.3 million, compared with $5.5 million a year earlier, reflecting a gross margin near 36%.
The company posted a GAAP net loss of $0.01 per share, roughly in line with analyst expectations. On a nine-month basis, revenue reached approximately $42.9 million, up from $40.3 million in the same period of 2025, underscoring continued top-line expansion despite the quarterly softness.
Total scheduled backlog stood at $254.5 million as of September 30, 2026, consisting of $18.2 million in funded backlog and $236.3 million in unfunded backlog, down from $271.7 million at June 30, 2026. Notably, the qualified opportunity pipeline rose to approximately $1.66 billion, up from $953.5 million three months prior, signaling a much larger set of prospective awards ahead.
Market Reaction and Investor Sentiment
Investor sentiment heading into the report was cautious, given that CTM shares had already fallen more than 50% over the trailing twelve months and sat near their 52-week lows. The modest revenue shortfall and declining backlog reinforced those concerns, and the stock dropped sharply in after-hours trading following the November 5 release, briefly trading below $0.45 per share. The sharp pullback suggests investors were focused primarily on the top-line miss and the sequential decline in backlog, even as the company highlighted a dramatically expanded opportunity pipeline. The market's reaction reflects a degree of skepticism about how quickly that larger pipeline will translate into booked and funded contracts.
Forward Outlook and Key Factors to Monitor
Looking ahead, the central question for Castellum is execution: whether its substantially larger qualified opportunity pipeline can convert into awarded and funded contracts that restore backlog growth and drive recognized revenue. A rising pipeline without corresponding awards does little to change near-term financials, so investors should watch future contract announcements and backlog composition closely.
Cost discipline and margins remain another key area. The company has emphasized managing the business for positive cash flow rather than GAAP profitability, given the meaningful non-cash charges it absorbs. Maintaining gross margins near current levels while scaling revenue will be important for sustaining that strategy.
Finally, the broader defense and federal IT spending environment will shape demand. Castellum's focus on cybersecurity, electronic warfare, and mission-critical software positions it within priority areas of government spending, but timing of budget execution and contract awards can be uneven. Investors should monitor upcoming award announcements, backlog trends in the next quarterly release, and any commentary on M&A, which management has cited as a potential lever for long-term growth.
Exploring AI Tools in My Research
From what I see, tools like Tickeron's AI Screener have become a regular part of how I scan for defense and tech names that might fit similar profiles. It helps surface comparable setups across sectors without spending hours on manual filters, which keeps my focus on the numbers that actually matter for names like CTM.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CTM in -5.78% downward trend, falling for three consecutive days on November 02, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CTM declined for three days, in 302 of 341 cases, the price declined further within the following month. The odds of a continued downward trend are 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTM as a result. In 76 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for CTM turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 36 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
The Aroon Indicator for CTM entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for CTM's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTM advanced for three days, in 191 of 228 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CTM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.251) is normal, around the industry mean (2.873). P/E Ratio (-15.790) is within average values for comparable stocks, (18.687). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.239) among similar stocks. P/S Ratio (1.076) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CTM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InformationTechnologyServices
Advertisement